The CAIRO4 study:The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)

BACKGROUND: There is no consensus regarding resection of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastatic colorectal cancer (CRC). A potential benefit of resection of the primary tumour is to prevent complications of the primary tumour in later stages of the disease. We here propose a randomized trial in order to demonstrate that resection of the primary tumour improves overall survival. METHODS/DESIGN: The CAIRO4 study is a multicentre, randomized, phase III study of the Dutch Colorectal Cancer Group (DCCG). Patients with synchronous unresect... Mehr ...

Verfasser: 't Lam-Boer, Jorine
Mol, Linda
Verhoef, Cornelis
de Haan, Anton F J
Yilmaz, Mette
Punt, Cornelis J A
de Wilt, Johannes H W
Koopman, Miriam
Dokumenttyp: Artikel
Erscheinungsdatum: 2014
Reihe/Periodikum: 't Lam-Boer , J , Mol , L , Verhoef , C , de Haan , A F J , Yilmaz , M , Punt , C J A , de Wilt , J H W & Koopman , M 2014 , ' The CAIRO4 study : The role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer--a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG) ' , B M C Cancer , vol. 14 , 741 . https://doi.org/10.1186/1471-2407-14-741
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27468138
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://vbn.aau.dk/da/publications/a5898868-0b5a-49b9-911c-2ac51ceeea9e